+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Venous Stents - Global Strategic Business Report

  • PDF Icon

    Report

  • 193 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5141272
The global market for Venous Stents was estimated at US$1.2 Billion in 2023 and is projected to reach US$2.1 Billion by 2030, growing at a CAGR of 8.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Venous Stents Market - Key Trends & Growth Drivers Explored

Why Are Venous Stents Gaining Importance in Vascular Disease Management?

Venous stents have emerged as a crucial tool in the management of chronic venous diseases, offering a minimally invasive solution for patients suffering from venous obstructions, deep vein thrombosis (DVT), and other vascular conditions. But what makes these devices so essential in modern vascular care? Venous stents are small, mesh-like metal tubes inserted into veins to restore proper blood flow and prevent vein collapse or blockage. They are specifically designed to address venous insufficiencies, a condition where veins are unable to effectively return blood from the lower extremities back to the heart, causing symptoms like pain, swelling, and varicose veins. Unlike arterial stents, which are used in arteries that handle high-pressure blood flow, venous stents are optimized for veins with lower blood pressure and different structural characteristics. Their design ensures flexibility and conformity to the vessel wall, making them highly effective for maintaining vein patency and alleviating symptoms associated with venous obstruction.

The demand for venous stents is driven by the increasing prevalence of chronic venous disorders, which affect millions of people worldwide and can lead to severe complications if left untreated. Traditional treatment options, such as compression therapy and anticoagulant medication, often fall short in managing advanced cases of venous obstruction, making stenting a preferred therapeutic option. Venous stents offer a long-lasting solution by physically opening narrowed or blocked veins, thereby improving blood flow and reducing the risk of complications like leg ulcers and recurrent thrombosis. The adoption of venous stents is particularly prevalent in the treatment of conditions such as post-thrombotic syndrome (PTS) and iliac vein compression syndrome (May-Thurner syndrome), where stenting has been shown to significantly improve patient outcomes and quality of life. As awareness of venous diseases and the benefits of stenting continues to grow, healthcare providers are increasingly opting for venous stents as a first-line intervention for complex venous pathologies.

How Are Technological Innovations Enhancing the Effectiveness of Venous Stents?

The venous stents market has witnessed significant technological advancements that have improved the safety, efficacy, and durability of these devices. But what are the key innovations driving these developments? One of the most notable advancements is the development of dedicated venous stent designs that address the unique anatomical and physiological challenges of veins. Traditional stents, initially designed for arterial applications, often struggled to provide optimal outcomes when used in venous settings due to the different biomechanical properties of veins. In response, manufacturers have introduced venous-specific stents with features such as greater flexibility, radial force, and resistance to kinking and compression. These stents are engineered to conform to the venous anatomy, even in tortuous or highly curved vessels, ensuring long-term patency and minimizing the risk of migration or fracture. Additionally, the use of nitinol and cobalt-chromium alloys in stent construction has enhanced their strength and elasticity, making them better suited for large-diameter veins and high-compression areas.

Another critical innovation is the introduction of drug-eluting venous stents, which are coated with pharmacological agents that prevent excessive tissue growth and reduce the risk of in-stent restenosis. This technology, already successful in arterial stents, has shown promise in venous applications, where the risk of restenosis is a significant concern. Drug-eluting stents release anti-proliferative drugs over time, inhibiting the growth of scar tissue within the stent and maintaining lumen patency. Moreover, advancements in imaging technologies, such as intravascular ultrasound (IVUS) and digital subtraction angiography (DSA), have enhanced the precision of stent placement, allowing for more accurate assessment of vein morphology and ensuring that the stent is optimally positioned. The integration of these technologies has not only improved the safety and efficacy of venous stents but has also expanded their use in more complex cases, such as multi-level venous obstructions and recurrent DVT. As a result, the effectiveness of venous stents in treating a broader range of venous diseases has been significantly enhanced, driving their adoption in clinical practice.

What Market Trends Are Driving the Adoption of Venous Stents in Vascular Treatment?

Several emerging market trends are shaping the adoption of venous stents in vascular treatment, reflecting the evolving needs of both patients and healthcare providers. One of the most prominent trends is the increasing focus on minimally invasive procedures. As patients and clinicians prioritize faster recovery times, lower complication rates, and reduced hospital stays, there has been a strong shift towards endovascular treatments for venous diseases. Venous stenting, as a minimally invasive option, offers a less traumatic alternative to traditional open surgery, making it a preferred choice for managing chronic venous insufficiency and venous obstructions. This trend is particularly evident in developed regions, where advanced healthcare infrastructure and high patient awareness levels support the widespread adoption of minimally invasive techniques. The shift towards outpatient procedures has also driven the demand for venous stents, as these devices can often be implanted in a same-day setting, minimizing disruption to patients' daily lives.

Another significant trend driving the adoption of venous stents is the growing recognition of chronic venous disorders as a major public health issue. With an aging global population and rising incidence of risk factors such as obesity, sedentary lifestyles, and prolonged immobility, the prevalence of venous diseases is on the rise. This has led to increased awareness among healthcare providers and patients about the importance of early diagnosis and intervention. As a result, there is a growing emphasis on screening and treating venous obstructions before they lead to more severe complications, such as venous ulcers or pulmonary embolism. The adoption of venous stents has been further supported by the publication of clinical guidelines and consensus statements that highlight the role of stenting in managing venous diseases. These guidelines, issued by leading vascular societies, have provided clarity on patient selection, procedural techniques, and post-procedure management, facilitating more widespread and standardized use of venous stents across clinical settings. These trends reflect a broader shift towards more proactive and effective management of venous diseases, positioning venous stents as a cornerstone of modern vascular treatment strategies.

What Factors Are Driving the Growth of the Global Venous Stents Market?

The growth in the global venous stents market is driven by several factors, including advancements in stent technology, increasing prevalence of venous disorders, and the rising demand for minimally invasive procedures. One of the primary growth drivers is the expanding use of venous stents in the treatment of complex venous pathologies, such as PTS and iliac vein compression. As awareness of these conditions grows and diagnostic capabilities improve, more patients are being identified as candidates for stenting, leading to increased demand for venous stents. The availability of dedicated venous stents that are specifically designed to address the challenges of venous anatomy has also contributed to market growth, as these devices offer better clinical outcomes compared to traditional stents. The development of next-generation stents with enhanced flexibility, radial strength, and resistance to compression has further expanded the range of patients who can benefit from venous stenting, driving adoption in both primary and recurrent cases of venous obstruction.

Another key growth driver is the increasing investment in research and development by medical device companies. As competition intensifies, manufacturers are focusing on developing innovative venous stents with improved designs and advanced coatings to address the unmet needs of patients and clinicians. Clinical trials and studies demonstrating the long-term safety and efficacy of these new stents are helping to build confidence among healthcare providers, encouraging more widespread use of these devices in clinical practice. Additionally, the rising burden of chronic venous diseases, particularly in aging populations, is creating a need for more effective treatment options. The prevalence of venous disorders is expected to increase as the global population ages, further fueling demand for venous stents. With supportive reimbursement policies and the growing recognition of the clinical benefits of stenting, the global venous stents market is poised for sustained growth, driven by a dynamic interplay of technological innovation, clinical adoption, and demographic trends.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Iliac Vein Stent Technology segment, which is expected to reach US$1.4 Billion by 2030 with a CAGR of a 8.3%. The Wallstent Technology segment is also set to grow at 8.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $319.0 Million in 2023, and China, forecasted to grow at an impressive 11.2% CAGR to reach $474.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Venous Stents Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Venous Stents Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Venous Stents Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Venous Stents market such as BARD, A Becton, Dickinson Company, Boston Scientific Corporation, Cook Medical LLC, Gore Medical, Jotec GmbH and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 43 companies featured in this Venous Stents market report include:

  • BARD, A Becton, Dickinson Company
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Gore Medical
  • Jotec GmbH
  • OptiMed Medizinische Instrumente GmbH

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Venous Stents - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Chronic Venous Insufficiency and Deep Vein Thrombosis Drives Demand for Venous Stents
  • Increased Adoption of Minimally Invasive Vascular Procedures Expands Addressable Market for Venous Stents
  • Surge in Demand for Venous Stents in Post-Thrombotic Syndrome Treatment Fuels Market Growth
  • Rising Adoption of Venous Stents in Outpatient and Ambulatory Surgical Centers Sets the Stage for Market Growth
  • Surge in Use of Venous Stents for Treating Pelvic and Iliac Vein Compression Expands Market Opportunities
  • Technological Innovations in Drug-Eluting and Bioabsorbable Venous Stents Propel Market Growth
  • Rising Utilization of Venous Stents in Cancer and Post-Surgical Complications Fuels Market Demand
  • Surge in Adoption of Venous Stents in Pediatric and Geriatric Venous Disorders Expands Market Opportunities
  • Technological Advancements in Imaging and Navigation Systems for Venous Stenting Propel Market Growth
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Venous Stents Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Venous Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Venous Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Venous Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Iliac Vein Stent Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Iliac Vein Stent Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Iliac Vein Stent Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Wallstent Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Wallstent Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Wallstent Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Leg by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Leg by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Leg by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Chest by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Chest by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Chest by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Abdomen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Abdomen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Abdomen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Arm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Arm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Arm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Chronic Deep Vein Thrombosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 24: World Historic Review for Chronic Deep Vein Thrombosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 25: World 16-Year Perspective for Chronic Deep Vein Thrombosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Post Thrombotic Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 27: World Historic Review for Post Thrombotic Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 28: World 16-Year Perspective for Post Thrombotic Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 29: World Recent Past, Current & Future Analysis for May-Thurner Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 30: World Historic Review for May-Thurner Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 31: World 16-Year Perspective for May-Thurner Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 32: World Recent Past, Current & Future Analysis for Hemodialysis/Arteriovenous Fistulae by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 33: World Historic Review for Hemodialysis/Arteriovenous Fistulae by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 34: World 16-Year Perspective for Hemodialysis/Arteriovenous Fistulae by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 35: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 36: World Historic Review for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 37: World 16-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
CANADA
JAPAN
  • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
CHINA
  • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
EUROPE
  • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
FRANCE
  • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
GERMANY
  • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
ITALY
UNITED KINGDOM
  • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
AUSTRALIA
  • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned

  • BARD, A Becton, Dickinson Company
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Gore Medical
  • Jotec GmbH
  • OptiMed Medizinische Instrumente GmbH

Table Information